Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
The DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.
Abstract
This report summarizes recommendations from the ACNP Task Force on the conceptualization of remission and its implications for defining recovery, relapse, recurrence, and response for clinical investigators and practicing clinicians. Given the strong implications of remission for better function and a better prognosis, remission is a valid, clinically relevant end point for both practitioners and investigators. Not all depressed patients, however, will reach remission. Response is a less desirable primary outcome in trials because it depends highly on the initial (often single) baseline measure of symptom severity. It is recommended that remission be ascribed after 3 consecutive weeks during which minimal symptom status (absence of both sadness and reduced interest/pleasure along with the presence of fewer than three of the remaining seven DSM-IV-TR diagnostic criterion symptoms) is maintained. Once achieved, remission can only be lost if followed by a relapse. Recovery is ascribed after at least 4 months following the onset of remission, during which a relapse has not occurred. Recovery, once achieved, can only be lost if followed by a recurrence. Day-to-day functioning and quality of life are important secondary end points, but they were not included in the proposed definitions of response, remission, recovery, relapse, or recurrence. These recommendations suggest that symptom ratings that measure all nine criterion symptom domains to define a major depressive episode are p…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both reports explicitly requested empirical validations of these now widely used consensus-based definitions.”
From Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review (2019) · cites this paper as Rush et al. (2006)
In the citing paper
“Not only were the specific operationalisations of the duration criteria by Frank et al. (1991) and Rush et al. (2006) not empirically supported”
From Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review (2019) · cites this paper as Rush et al. 2006
In the citing paper
“This definition of relapse is the one most commonly used in clinical studies.39”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“These reports have relied on a variety of reasonably chosen remission end points at study exit (eg, 17-item Hamilton Rating Scale for Depression p7 or p6 (HRSD17; Hamilton, 1960, 1967) or MontgomeryÄsberg Depression Rating Scale p10 (MADRS; Montgomery and Äsberg, 1979)).”
MethodThe MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · cited 2×
“Several measures, including the Beck Depression Inventory (BDI) (Beck et al, 1961), Global Assessment Scale (GAS) (Endicott et al, 1976), Dysfunctional Attitudes Scale (DAS) (Weissman, 1979), and the Automatic Thoughts Questionnaire (ATQ) (Hollon and Kendall, 1980), gathered at acute trial exit,…”
MethodCognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“With medications, remission may begin within 4–12 weeks (or longer) after beginning treatment (O’Leary et al, 2000; Chilvers et al, 2001; Trivedi et al, 2001, 2006; Quitkin et al, 2003).”
BackgroundSelf-citationRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Self-citationMediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Self-citationThe Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 2×
“An HRSD17 p7 corresponds to an MADRS score p9 (Carmody et al, in press), or a 30-item Inventory of Depressive SymptomatologyFClinician-Rated (IDS-C30) score p12, an Inventory of Depressive SymptomatologyFSelf-Report (IDS-SR30) (Rush et al, 1996, 2003c) score p14, or a QIDS-C16 or QIDS-SR30 score of p5.”
MethodSelf-citation(2012) · SpringerReference · doi:10.1007/springerreference_179754 · Cited by 2,089
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 2×
“Given the relative paucity of studies aimed at validating the concepts put forth by Frank et al (1991), the panel chose to reach consensus on the specifics of the relevant concepts using the literature, clinical experience, and logic.”
BackgroundSelf-citation(1993) · PubMed · Cited by 1,900
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885 · cited 1×
“The NTT is the number of subjects that need to be treated in order to obtain one additional subject reaching remission at each follow-up time in the treatment over what would have been achieved in the control group (Cook and Sackett, 1995).”
BackgroundCohen, J. (1983) · Applied Psychological Measurement · doi:10.1177/014662168300700301 · Cited by 1,564
Cognitive self-statements in depression: Development of an automatic thoughts questionnaire
Hollon, S. D., & Kendall, P. C. (1980) · Cognitive Therapy and Research · doi:10.1007/bf01178214 · Cited by 1,480
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 1×
“In addition, it is suggested but not unequivocally established that long-standing (ie, chronic) depressions may take longer to remit or are less likely to remit (Prudic et al, 1996; Fava et al, 1997; Keller et al, 1998, 2000).”
BackgroundSelf-citationInterpersonal Psychotherapy Of Depression
Klerman, G. L. (1984) · Medical Entomology and Zoology · Cited by 1,315
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 1×
“…Network for Mood and Anxiety Treatements (CANMAT), 2001; Reesal and Lam, 2001; Bauer et al, 2002a, b; Hirschfeld et al, 1997; Ballenger, 1999; Trivedi et al, 1998; Crismon et al, 1999; Rush et al, 2003a, 2004; Fava et al, 2003b; the American Academy of Child and Adolescent Psychiatry, 1998).”
BackgroundSelf-citationKennedy, C. O. (1971) · British Homeopathic Journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 974
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Self-citationSackeim, H. A., Prudic, J., Devanand, D. P., Kiersky, J. E., Fitzsimons, L., Moody, B. J., McElhiney, M. C., Coleman, E. A., & Settembrino, J. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281204 · Cited by 940
Self-citationAnderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Hirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Interpersonal Psychotherapy of Depression
RUSH, A. J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1381 · Cited by 827
Self-citationBeck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbauch, J. (2011) · PsycTESTS Dataset · doi:10.1037/t00741-000 · Cited by 815
Sackeim, H. A., Prudic, J., Devanand, D. P., Nobler, M. S., Lisanby, S. H., Peyser, S., Fitzsimons, L., Moody, B. J., & Clark, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.425 · Cited by 804
Self-citationRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Self-citationResidual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 1×
“…depressive symptoms, have better function (Riso et al, 1997; Miller et al, 1998; Hirschfeld et al, 2002), a better prognosis (Thase et al, 1992; Paykel et al, 1995, 1999; Judd et al, 1998a, b, 1999; Simon et al, 2001; Fava et al, 2002; Kanai et al, 2003), and a more stable, enduring state…”
BackgroundJudd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.694 · Cited by 775
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686 · cited 2×
“One might consider identifying a provisional response when the response criterion is first met, then identifying a definite response when the response criterion is still met after an additional 2 weeks (Sackeim et al, 1987, 1993, 2000, 2001).”
BackgroundSelf-citationJudd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Treatments of Depression and the Functional Capacity to Work
Mintz, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100005001 · Cited by 563
Fava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeim, H. A., Quitkin, F. M., Wisniewski, S., Lavori, P. W., Rosenbaum, J. F., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00107-7 · Cited by 519
Self-citationResidual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470 · cited 1×
“For example, Nierenberg et al (1999) found that only 17.6% of patients with an HRSD17 p7 had no symptoms of MDD.”
MethodInfluentialSelf-citationHusain, M. M., Rush, A. J., Fink, M., Knapp, R., Petrides, G., Rummans, T., Biggs, M. M., O'Connor, K., Rasmussen, K., Litle, M., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0406 · Cited by 456
Self-citationFava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452 · cited 2×
“Regression to the mean may further foster the invalid impression of symptomatic improvement (Fava et al, 2003a).”
BackgroundResistance to antidepressant medications and short-term clinical response to ECT
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.985 · Cited by 436
Self-citationThe D ysfunctional Att itude Scale: A Validation Study
Weissman, A. (1979) · ScholarlyCommons (University of Pennsylvania) · Cited by 400
Rush, A. J., Sackeim, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Davis, S. M., Lavori, P., Howland, R., Kling, M. A., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.024 · Cited by 400
Self-citationRush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S., Mundt, J. C., Shores-Wilson, K., Biggs, M. M., Woo, A., Nierenberg, A. A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.022 · Cited by 385 · cited 1×
“However, clinician and patient rating scales that rate identical symptoms substantially increase agreement between these two perspectives (Rush et al, 2006; Trivedi et al, 2004b).”
BackgroundSelf-citationSACKEIM, H. A., PRUDIC, J., DEVANAND, D. P., DECINA, P., KERR, B., & MALITZ, S. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199004000-00004 · Cited by 361
Self-citationAgras, W. S., Crow, S. J., Halmi, K. A., Mitchell, J. E., Wilson, G. T., & Kraemer, H. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1302 · Cited by 346
Self-citationBauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Kendler, K. S. (1996) · PubMed · Cited by 341
Sackeim, H. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800160067009 · Cited by 333
Self-citationTrivedi, M. H., Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., Key, T., Biggs, M. M., Shores-Wilson, K., Witte, B., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.669 · Cited by 316
Self-citationBirmaher, B., & Brent, D. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199810001-00005 · Cited by 315
Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132448.65972.d9 · Cited by 314
Anderson, I. M., Nutt, D. J., & Deakin, J. F. W. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400101 · Cited by 310
Miller, I. W., Keitner, G. I., Schatzberg, A. F., Klein, D. N., Thase, M. E., Rush, A. J., Markowitz, J. C., Schlager, D. S., Kornstein, S. G., Davis, S. M., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1108 · Cited by 305
Self-citationContinuation drug therapy for major depressive episodes: how long should it be maintained?
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.18 · Cited by 295
Self-citationClinical guidelines for the treatment of depressive disorders.
(2001) · PubMed · Cited by 274
Effectiveness of electroconvulsive therapy in community settings
Prudic, J., Olfson, M., Marcus, S. C., Fuller, R. B., & Sackeim, H. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.015 · Cited by 269 · cited 2×
“…2004; Rush et al, 2003a; Bielski et al, 2004; Fava et al, 2004; Goldstein et al, 2004; Montgomery et al, 2004; Nelson et al, 2004; Perlis et al, 2004; Prudic et al, 2004; Trivedi et al, 2004a) and in pooled or meta-analyses (Lepola et al, 1998; Beasley et al, 2000; Entsuah et al, 2001; Thase et…”
BackgroundChilvers, C., Dewey, M., Fielding, K., Gretton, V., Miller, P., Palmer, B., Weller, D., Churchill, R., Williams, I., Bedi, N., et al. (2001) · BMJ · doi:10.1136/bmj.322.7289.772 · Cited by 267
Medication resistance and clinical response to electroconvulsive therapy
Prudic, J., Sackeim, H. A., & Devanand, D. P. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90098-p · Cited by 264
Self-citationGilbert, D. A., Altshuler, K. Z., Rago, W. V., Shon, S. P., Crismon, M. L., Toprac, M. G., & Rush, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0702 · Cited by 264
Self-citationKendler, K. S. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298437 · Cited by 262 · cited 1×
“As several anxiety disorders and MDD may share similar genetic background vulnerabilities (Kendler, 1996), the lack of response of anxiety symptoms in treatment trials may have implications for identifying different pathophysiological and diagnostic subtypes.”
BackgroundComorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
Rush, A. J., Zimmerman, M., Wisniewski, S. R., Fava, M., Hollon, S. D., Warden, D., Biggs, M. M., Shores-Wilson, K., Shelton, R. C., Luther, J. F., et al. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.005 · Cited by 254
Self-citation(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1046 · Cited by 252 · cited 1×
“…who have some residual depressive symptoms, have better function (Riso et al, 1997; Miller et al, 1998; Hirschfeld et al, 2002), a better prognosis (Thase et al, 1992; Paykel et al, 1995, 1999; Judd et al, 1998a, b, 1999; Simon et al, 2001; Fava et al, 2002; Kanai et al, 2003), and a more stable,…”
BackgroundSelf-citationRush, A. J. (1993) · Medical Entomology and Zoology · Cited by 250
Self-citationCrismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. M. A., Kahn, D. A., DeBattista, C., Nelson, J. C., Nierenberg, A. A., Sackeim, H. A., et al. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0302 · Cited by 250
Self-citationMajor depressive subtypes and treatment response
Fava, M., Uebelacker, L. A., Alpert, J. E., Nierenberg, A. A., Pava, J. A., & Rosenbaum, J. F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00440-4 · Cited by 247
Self-citationEntsuah, A. R., Huang, H., & Thase, M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1106 · Cited by 245
Self-citationThe Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures
Carmody, T. J., Rush, A. J., Bernstein, I., Warden, D., Brannan, S., Burnham, D., Woo, A., & Trivedi, M. H. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.04.008 · Cited by 245
Self-citationHirschfeld, R. M. A., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., Markowitz, J. C., Miller, I., Nemeroff, C. B., Ninan, P. T., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01291-4 · Cited by 231 · cited 2×
“…as compared to those who have responded but who have some residual depressive symptoms, have better function (Riso et al, 1997; Miller et al, 1998; Hirschfeld et al, 2002), a better prognosis (Thase et al, 1992; Paykel et al, 1995, 1999; Judd et al, 1998a, b, 1999; Simon et al, 2001; Fava et al,…”
BackgroundSelf-citationCiraulo, D. A. (2003) · JAMA · doi:10.1001/jama.289.23.3175-b · Cited by 231
Clinical guidelines for establishing remission in patients with depression and anxiety.
Ballenger, J. C. (1999) · PubMed · Cited by 218
Fava, M., Mallinckrodt, C. H., Detke, M. J., Watkin, J. G., & Wohlreich, M. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0411 · Cited by 212
Self-citationReimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Self-citationVenlafaxine for Treatment-Resistant Unipolar Depression
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00008 · Cited by 198
Cost-effectiveness of Systematic Depression Treatment for High Utilizers of General Medical Care
Simon, G. E., Manning, W. G., Katzelnick, D. J., Pearson, S. D., Henk, H. J., & Helstad, C. P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.181 · Cited by 198
ECT in bipolar and unipolar depression: differences in speed of response
Daly, J. J., Prudic, J., Devanand, D., Nobler, M. S., Lisanby, S. H., Peyser, S., Roose, S. P., & Sackeim, H. A. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030208.x · Cited by 191
Self-citationResearch issues in the study of difficult-to-treat depression
Rush, A. J., Thase, M. E., & Dubé, S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00088-x · Cited by 190
Self-citationNelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.3.345 · Cited by 183
Bielski, R. J., Ventura, D., & Chang, C.-C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0906 · Cited by 178 · cited 1×
“…as an outcome in acute phase efficacy trials of MDE (eg, Keller et al, 1998; Sackeim et al, 2000; Alpert et al, 2002, 2004; Rush et al, 2003a; Bielski et al, 2004; Fava et al, 2004; Goldstein et al, 2004; Montgomery et al, 2004; Nelson et al, 2004; Perlis et al, 2004; Prudic et al, 2004;…”
BackgroundSeizure threshold in electroconvulsive therapy: I. Initial seizure threshold
Coffey, C. E., Lucke, J., Weiner, R. D., Krystal, A. D., & Aque, M. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00262-f · Cited by 176
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1500 · Cited by 172
Self-citationRecovery and major depression: factors associated with twelve-month outcome
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.93 · Cited by 171
Montgomery, S. A., Huusom, A. K. T., & Bothmer, J. (2004) · Neuropsychobiology · doi:10.1159/000078225 · Cited by 168 · cited 1×
“…Keller et al, 1998; Sackeim et al, 2000; Alpert et al, 2002, 2004; Rush et al, 2003a; Bielski et al, 2004; Fava et al, 2004; Goldstein et al, 2004; Montgomery et al, 2004; Nelson et al, 2004; Perlis et al, 2004; Prudic et al, 2004; Trivedi et al, 2004a) and in pooled or meta-analyses (Lepola et…”
BackgroundKeller, M. B., Gelenberg, A. J., Hirschfeld, R. M. A., Rush, A. J., Thase, M. E., Kocsis, J. H., Markowitz, J. C., Fawcett, J. A., Koran, L. M., Klein, D. N., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1107 · Cited by 161
Self-citationBauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150605 · Cited by 160
Ormel, J., Oldehinkel, A. J., Nolen, W. A., & Vollebergh, W. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.387 · Cited by 154 · cited 2×
“Furthermore, premorbid functioning is highly predictive of posttreatment functioning in depression (Ormel et al, 2004).”
BackgroundTime to recurrence after recovery from major depressive episodes and its predictors
KANAI, T., TAKEUCHI, H., FURUKAWA, T. A., YOSHIMURA, R., IMAIZUMI, T., KITAMURA, T., & TAKAHASHI, K. (2003) · Psychological Medicine · doi:10.1017/s0033291703007827 · Cited by 140
Residual symptoms in depression
Fava, G. A., Fabbri, S., & Sonino, N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00226-9 · Cited by 137
Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression
Alpert, J. E., Mischoulon, D., Rubenstein, G., Bottonari, K. A., Nierenberg, A. A., & Fava, M. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1015271927517 · Cited by 134
Self-citationThe Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder
Iosifescu, D. V., Nierenberg, A. A., Alpert, J. E., Smith, M., Bitran, S., Dording, C., & Fava, M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2122 · Cited by 122
Self-citationDefining Remission on the Montgomery-Asberg Depression Rating Scale
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0204 · Cited by 117
A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder
Lepola, U. M., Wade, A. G., Leinonen, E. V., Koponen, H. J., Frazer, J., Sjodin, I., Penttinen, J. T., Pedersen, T., & Lehto, H. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1006 · Cited by 111
Texas Medication Algorithm Project, Phase 3 (TMAP-3): Rationale and Study Design
Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., Trivedi, M. H., Suppes, T., Miller, A. L., Biggs, M. M., Shores-Wilson, K., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0402 · Cited by 108
Self-citationZimmerman, M., Chelminski, I., & Posternak, M. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200401000-00001 · Cited by 105
Ghatavi, K., Nicolson, R., MacDonald, C., Osher, S., & Levitt, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00335-4 · Cited by 104
When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?
Quitkin, F. M., Petkova, E., McGrath, P. J., Taylor, B., Beasley, C., Stewart, J., Amsterdam, J., Fava, M., Rosenbaum, J., Reimherr, F., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.734 · Cited by 100
Self-citationThe relations between observer-rating and self-report of depressive symptomatology.
Sayer, N. A., Sackeim, H. A., Moeller, J. R., & Prudic, J. (1993) · Psychological Assessment · doi:10.1037//1040-3590.5.3.350 · Cited by 95
Self-citationJudd, L. L., Paulus, M. P., & Zeller, P. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.764 · Cited by 90
Remission onset and relapse in depression
O’Leary, D., Costello, F., Gormley, N., & Webb, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00086-5 · Cited by 87
The Dysfunctional Attitude Scale: how well can it measure depressive thinking
Nelson, L. D., Stern, S. L., & Cicchetti, D. V. (1992) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/bf00962629 · Cited by 87
Riso, L. P., Thase, M. E., Howland, R. H., Friedman, E. S., Simons, A. D., & Tu, X. M. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)01420-6 · Cited by 81
Self-citationTreatment of Chronic Depression
Scott, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422010 · Cited by 76
Outcome Definitions and Predictors in Depression
Tedlow, J., Fava, M., Uebelacker, L., Nierenberg, A. A., Alpert, J. E., & Rosenbaum, J. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012290 · Cited by 75
Self-citationReliability of treadmill exercise testing in older patients with chronic hemiparetic stroke
Dobrovolny, C. L., Ivey, F. M., Rogers, M. A., Sorkin, J. D., & Macko, R. F. (2003) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(03)00150-3 · Cited by 74
Sertraline versus imipramine to prevent relapse in chronic depression
Koran, L. M., Gelenberg, A. J., Kornstein, S. G., Howland, R. H., Friedman, R. A., DeBattista, C., Klein, D. N., Kocsis, J. H., Schatzberg, A. F., Thase, M. E., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00272-x · Cited by 71
Self-citationPsychosocial predictors of outcome in major depression: a prospective 12-month study
Ezquiaga, E., Garcı́a, A., Pallarés, T., & Bravo‐Ortiz, M. F. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00057-3 · Cited by 70
Small, G. W., Birkett, M., Meyers, B. S., Koran, L. M., Bystritsky, A., Nemeroff, C. B., & Fluoxetine Collaborative Study Group (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01373.x · Cited by 65
Beasley, C. M., Nilsson, M. E., Koke, S. C., & Gonzales, J. S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1003 · Cited by 62
Clinical guidelines for the treatment of depressive disorders. II. Principles of management.
Reesal, R. T., & Lam, R. W. M. (2001) · PubMed · Cited by 61
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000130232.57629.46 · Cited by 61
Fritzler, M. J., Wiik, A. S., Tan, E. M., Smolen, J. S., McDougal, J. S., Chan, E. K. L., Gordon, T. P., Hardin, J., Kalden, J. R., Lahita, R. G., et al. (2003) · PubMed · Cited by 50
Is remission of depressive symptoms in primary care a realistic goal? A meta-analysis
Dawson, M. Y., Michalak, E. E., Waraich, P. S., Anderson, J. E., & Lam, R. W. M. (2004) · BMC Family Practice · doi:10.1186/1471-2296-5-19 · Cited by 39
Dr. Keitner and Associates Reply
Keitner, G. I., Miller, I. W., RYAN, C. E., & Norman, W. H. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1128 · Cited by 34
Partial remission in major depression: A two-phase, 12-month prospective study
Viinamäki, H., Hintikka, J., Tanskanen, A., Honkalampi, K., Antikainen, R., Koivumaa-Honkanen, H., Haatainen, K., Saarinen, P., & Lehtonen, J. (2002) · Nordic Journal of Psychiatry · doi:10.1080/08039480252803891 · Cited by 31
Gepirone Extended-Release Treatment of Anxious Depression
Alpert, J. E., Franznick, D. A., Hollander, S. B., & D, M. F. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0807 · Cited by 30
Self-citationPerlis, R. H., Iosifescu, D. V., Alpert, J. E., Nierenberg, A. A., Rosenbaum, J. F., & Fava, M. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.3.224 · Cited by 28
Self-citationWhich Depressed Patients Respond to Nefazodone and When?
Trivedi, M. H., Rush, A. J., Pan, J.-Y., & Carmody, T. J. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0304 · Cited by 27
Self-citationBaca‐García, E., Blanco, C., Sáiz, P. A., Rico, F., Díaz-Sastre, C., & Cicchetti, D. V. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00249-9 · Cited by 25
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20 · cited 1×
“…depressive symptoms, have better function (Riso et al, 1997; Miller et al, 1998; Hirschfeld et al, 2002), a better prognosis (Thase et al, 1992; Paykel et al, 1995, 1999; Judd et al, 1998a, b, 1999; Simon et al, 2001; Fava et al, 2002; Kanai et al, 2003), and a more stable, enduring state…”
BackgroundTrivedi, M. H., DeBattista, C., FAWCETT, J. A., et al. (1998) · PubMed · Cited by 20
Self-citationThe Definition of Remission and Its Impact on the Length of a Depressive Episode
Philipp, M. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170093013 · Cited by 15
The Development of Study Exit Criteria for Evaluating Antimanic Compounds
Frank, E., Kupfer, D. J., Gerebtzoff, A., Meya, U., Laghrissi‐Thode, F., Grochocinski, V. J., Houck, P. R., Mallinger, A. G., & Gibbons, R. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0604 · Cited by 13
Self-citationFears, T. R., Ziegler, R. G., Donaldson, J. L., Falk, R. T., Hoover, R. N., Stanczyk, F. Z., Vaught, J. B., & Gail, M. H. (2002) · PubMed · Cited by 9
Primary Standardization of Assays for Anticonvulsant Drugs: Comparison of Accuracy and Precision
Wilson, J. F., Watson, I. D., Williams, J., et al. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.11.1963 · Cited by 5
Research works printed but not linked: 2
- American Psychiatric Association (2000b). Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 (Suppl 4): 1–45.
- Weissman AN (1979). The dysfunctional attitude scale. A validation study. Diss Abst Int 40: 1389B–1390B.
Cited by
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationPRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Self-citationBlumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092
Manber, R., Edinger, J. D., Gress, J. L., Pedro-Salcedo, M. G. S., Kuo, T. F., & Kalista, T. (2008) · Sleep · doi:10.1093/sleep/31.4.489 · Cited by 868
Metadata
- Authors
- Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., Regier, D. A., Rosenbaum, J. F., Ray, O., & Schatzberg, A. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Stanford Medicine (US)
- University of Pittsburgh (US)
- Emory University (US)
- University of Arizona (US)
- American Psychiatric Association (US)
- Harvard University (US)
- Vanderbilt University (US)
- Corresponding author
- Rush, A John
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2006-06-21
- Volume
- 31
- Issue
- 9
- Pages
- 1841-1853
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2039979496
- Cited by
- 707
- References
- 132
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 29 · 2023: 58 · 2022: 30 · 2021: 47 · 2020: 30 · 2019: 47 · 2018: 35 · 2017: 30 · 2016: 41 · 2015: 33 · 2014: 32 · 2013: 36 · 2012: 35
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- major depressive disorder, remission, response, recovery, relapse, recurrence, end points, symptom rating scales, DSM-IV-TR diagnostic criteria, clinical trial results, quality of life
- MeSH terms
- Clinical Trials as Topic, Major Depressive Disorder, Humans, Recurrence, Research Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.